Shandong Xinhua Pharmaceutical Co. Ltd (0719.HK) revealed earnings for full year that Dropped, from the same period last year
The company's bottom line totaled RMB306.30 million, or RMB0.42 per share. This compares with RMB486.71 million, or RMB0.68 per share, last year.
The company's revenue for the period rose 3.4% to RMB8.754 billion from RMB8.466 billion last year.
Shandong Xinhua Pharmaceutical Co. Ltd earnings at a glance (GAAP) :
-Earnings: RMB306.30 Mln. vs. RMB486.71 Mln. last year.-EPS: RMB0.42 vs. RMB0.68 last year.-Revenue: RMB8.754 Bln vs. RMB8.466 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.